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Background: It was previously known that anuric acute kidney injury (AKI) is
uncommon and its occurrence suggests complete ureteral obstruction, shock, or a
major vascular event. As the epidemiology of AKI has signiﬁcantly changed over the
past decade, it is possible that the incidence, etiology, or clinical characteristics of
anuric AKI have also changed.
Methods: A prospective cohort study was conducted that included all patients
undergoing renal replacement therapy (RRT) for AKI during a 2-year period in a
tertiary hospital. Patients were classiﬁed as having anuric, oliguric, or nonoliguric
AKI based on their volume of urine when RRT started using the modiﬁed Acute
Kidney Injury Network criteria.
Results: Of the 203 patients included in the study, 21.2% met the criteria for anuric
AKI. Septic and postoperative AKI were the main causes of anuric AKI, with 60.5%
of incidences occurring in hospital. Anuric AKI was associated with a younger age, a
lower prevalence of pre-morbid chronic kidney disease and diabetes, more frequent
continuous RRT requirement, and multi-organ dysfunction. In addition, patients
with anuric AKI had a higher rate of in-hospital mortality and long-term depen-
dence on RRT than patients with nonanuric AKI.
Conclusion: Anuric AKI is common, with sepsis as the main etiological insult, and
is associated with adverse outcomes among patients with AKI who require RRT.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Acute kidney injury (AKI) may be described clinically as
oliguric, nonoliguric, or anuric [1,2]. These categories may help
to identify the cause and predict the prognosis of each episode




o).and therapeutic strategies. Classically, anuric AKI has been
reported to be uncommon and is associated with complete
ureteral obstruction, shock, or a major vascular event such as
bilateral renal artery occlusion and cortical necrosis [1].
The incidence of AKI has been increasing recently and sig-
niﬁcant changes have occurred in the epidemiology of AKI during
the past decade [3]. Several factors, such as older patients and a
higher burden of illness, including signiﬁcant comorbidities, might
contribute to the increased incidence of AKI. In addition, patients
are now more likely to undergo invasive diagnostic testing and
complex surgery or interventions. There is a possibility that thehrology. Published by Elsevier. This is an open access article under the
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has recently been more commonly encountered in clinical practice
even in patients without shock. Nevertheless, information is
limited regarding the epidemiology of anuric AKI, although a
number of anecdotal case reports have been published.
The aim of this study was to examine the causes, char-
acteristics, and outcomes of patients with anuric AKI and to
compare these ﬁndings with those for patients with nonanuric
AKI. As virtually all patients who are anuric for Z24 hours
receive emergency renal replacement therapy (RRT), we
selected those patients with the most severe form of AKI –
that is, those who required RRT stage 3 based on the Acute
Kidney Injury Network (AKIN) criteria [4]—to obtain similar
clinical levels of AKI severity in the patients with anuric and
nonanuric AKI. We determined the epidemiology of patients
with AKI who required dialysis, considering, in particular, the
volume of urine at the time of initiation of RRT and the
association between urine volume and outcomes, including
mortality and long-term dependence on RRT.Methods
Study population and design
Between March 2010 and February 2012, all adult patients
who received RRT for AKI were entered into a prospective
registry at the Korea University Anam Hospital, Seoul, Korea.
We included patients from both the intensive care unit (ICU;
medical, surgical, and cardiac units) and general wards. Emer-
gency RRT encompassed intermittent hemodialysis (IHD) and
continuous RRT (CRRT), with the ICU offering both IHD and CRRT.
The decision to start RRT was made by the nephrologists at the
hospital based on the patients’ clinical condition. The study was
approved by the Institutional Review Board of the university and
written informed consent was obtained from all patients.
We excluded patients with pre-existing advanced chronic
kidney disease (CKD)—that is, any evidence of CKD stage 4 or
clinically evident end-stage renal disease—for the following
reasons: (1) when patients with advanced CKD receive unplanned
dialysis, it is often unclear whether this is a result of AKI in
addition to CKD, or a rapid progression of their CKD; and (2) the
wide range of patients with CKD could have confounding effects
on the results. Patients with terminal cancer or those who died
within 48 hours of the start of RRT were also excluded because
they are commonly in the ﬁnal stages of multiple organ dysfunc-
tion syndrome (MODS), which is fatal.
The etiology was determined by the nephrologists based on
the clinical diagnosis. When more than one etiology contributed
to the AKI, the main factor was considered for the analysis.
Data collection and deﬁnitions
Oliguric AKI was deﬁned as a urine output of o7.2 mL/kg in
24 hours or anuria for 12 hours using the modiﬁed AKIN
criteria at the time of initiation of RRT (within 1 day prior to
or after the day of acute dialysis). However, oliguric patients
with AKI with a urine volume of o50 mL/d were classiﬁed as
having anuric AKI. Anuria that started several days after the
initiation of RRT was not deﬁned as anuric AKI.
The CKD status was determined by evaluating the available
data and history for each patient. CKD was deﬁned according to
the National Kidney Foundation classiﬁcation, including knownglomerulopathy or structural abnormality with normal estimated
glomerular ﬁltration rate (eGFR) [5], where CKD(3) included only
patients with CKD stage 3. Patients without previous data, but
who had an eGFR Z60 mL/min/1.73 m2 during the follow-up
period were considered to have no prior CKD.
Hepatorenal syndrome was deﬁned according to the 2007
revised hepatorenal syndrome criteria, which include infection
as the cause [6]. Cardiorenal syndrome (CRS) was indicated as
the main factor in patients with type 1 CRS as deﬁned by the
Acute Dialysis Quality Initiative consensus [7]. Hypovolemia
was determined as the cause of AKI in patients with massive
bleeding (e.g., from obstetric or gastrointestinal causes) or
evident dehydration. Hospital-acquired AKI (HA-AKI) was
deﬁned as AKI occurring during admission to hospital,
whereas community-acquired AKI (CA-AKI) was deﬁned as
AKI developing outside the hospital setting. MODS was deﬁned
as a patient with at least two of the following criteria: hepatic
failure, heart failure, respiratory failure, or coagulopathy
(disseminated intravascular coagulation).
The outcomes assessed included in-hospital mortality, 90-day
survival, and long-term dialysis dependence (RRT for 43 months,
class E based on the Risk Injury Failure Loss End-Stage outcome
criteria).
Statistical analysis
SPSS software, version 14.0 (SPSS Inc., Chicago, IL, USA) was
used for the statistical analysis. Data are presented as mean7
standard deviation values or as absolute numbers with per-
centages. Comparisons between groups were performed using
the Student t test, one-way analysis of variance, the χ2 test, or
Fisher’s exact test, as appropriate.
We identiﬁed the prognostic factors for the 90-day survival in a
Cox proportional hazards model by calculating the crude and
adjusted hazard ratios. Variables with Po0.05 in the univariate
analyses were assessed as independent predictors using the
multivariate model by the forward conditional method. We used
Kaplan–Meier curves to demonstrate the relationship between the
urine volume and survival. A log-rank test was used to compare
the differences in survival.
Results
Study cohort
RRT was performed in 304 patients during the study period
and 203 patients were included in the study (Fig. 1). Of the 101
patients excluded from the ﬁnal study, 64 patients died within
48 hours of the initiation of RRT and 11 patients had pre-
existing advanced CKD.
Of the 203 patients included in the study, 43 (21.2%) had
anuria at the initiation of RRT despite supportive care, including
hydration and diuretic drugs. Fifty-seven patients (28.1%) and
103 patients (50.7%) met the criteria for oliguric and nonoliguric
AKI, respectively. A diuretic challenge with furosemide was
administered in all patients with anuria and oliguria. We
monitored and recorded the patients’ urine output throughout
the course of the treatment.
Etiology of anuric AKI
Table 1 gives the causes of AKI among patients with anuric,
oliguric, and nonoliguric AKI. Sepsis was the most common









Hospital-acquired AKI 26 (60.5) 29 (50.9) 33 (32.0)
Cause of AKI
Sepsis 18 (41.8) 29 (50.9) 49 (47.6)
Postoperative AKI 13 (30.2) 7 (12.3) 2 (1.9)
Cardiorenal syndrome 5 (11.6) 5 (8.8) 9 (8.7)
Hepatorenal
syndrome
2 (4.7) 2 (3.5) 1 (1.0)
Nephrotoxic drugs 1 (2.3) 2 (3.5) 10 (9.7)
Postrenaln – – 11 (10.7)
Hypovolemia – 3 (5.3) 10 (9.7)
Vasculitis,
glomerulopathy
1 (2.3) 1 (1.8) 4 (3.9)
Rhabdomyolysis 1 (2.3) 4 (7.0) –
Other 2 (4.7) 4 (7.0) 7 (6.8)
n Urinary tract obstruction from stone, malignancy etc.
Data are presented as n (%).
AKI, acute kidney injury.
Patients received RRT for AKI (n=304) 
Patients excluded (n=87)
· death 48 hr within initiation of RRT (n=64) 
· terminal stage of cancer (n=12)
· underlying advanced CKD (n=11)
Patients withdrawn (n=14)
· give up further treatment or transfer (n=10) 
· others (n=4) 
Patients included in the study (n=203) 
Figure 1. Study cohort.
AKI, Acute kidney injury; CKD, chronic kidney disease; RRT, renal replacement therapy.
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tively). In patients with anuric AKI, postoperative AKI and CRS
were the other main causes of AKI (30.2% and 11.6%, respec-
tively). Classically well-known etiologies of anuric AKI, such
as complete ureteral obstruction or a major vascular event,
were rarely observed. Of note, postoperative AKI accounted
for nearly one-third of patients with anuric AKI. Of the 13
patients with postoperative anuric AKI, seven had undergone
gastrointestinal surgery and two had undergone transplanta-
tion (1 heart transplantation and 1 liver transplantation).
Postoperative AKI developed a median (range) of 2 (1–5) days
after surgery. The other causes of anuric AKI included hepa-
titis A and biopsy-proven acute tubulo-interstitial nephritis of
unknown cause. The leading causes of nonoliguric AKI, other
than sepsis, were postrenal (obstructive nephropathy from
stones, malignancy etc), nephrotoxic drugs (or toxins), and
hypovolemia (10.7%, 9.7%, and 9.7%, respectively).
In 48 patients (23.6%), multiple etiologies were thought to
have contributed to the development of AKI, such as sepsiscombined with drug administration. Overall, 43.3% of the cases
of AKI requiring RRT occurred in hospital. HA-AKI was sig-
niﬁcantly more common in patients with anuric AKI than in
patients with nonanuric AKI (60.5% vs. 38.8%, P¼0.015). Sepsis
was the major etiology of CA-anuric AKI (58.8%), whereas
postoperative AKI was the major component of HA-anuric AKI
(50.0%).
Characteristics of patients with anuric AKI
Table 2 gives the baseline demographics of the patients.
There was a trend for patients with anuric AKI to be younger
than those with nonanuric AKI (59.4719.9 vs. 65.4714.6,
P¼0.058). Interestingly, the prevalence of underlying CKD was
lower in the anuric AKI group than in the nonanuric group
[26.3% vs. 41.9%, P¼0.046 for CKD; 21.1% vs. 36.9%, P¼0.056,
for CKD(3)]. The prevalence of diabetes was also signiﬁcantly
lower in the anuric AKI group than in the nonanuric AKI group
(22.0% vs. 40.5%, P¼0.030).
Table 3 presents a comparison of the clinical characteristics
among patients with anuric, oliguric, and nonoliguric
AKI. Serum creatinine (Cr) levels at the time of initiation of
RRT were slightly lower in patients with anuric AKI and
oliguric AKI than in patients with nonoliguric AKI, suggesting
a delayed initiation of RRT when the urine output was
maintained (4.0472.57 vs. 4.9072.91, P¼0.05). However,
peak serum Cr levels were not different among the
three groups. Overall, 46.8% and 43.8% of the entire cohort
received vasoactive drugs and mechanical ventilation at
the time of initiation of RRT, respectively, with no signiﬁcant
difference among the groups. However, patients with
anuric AKI were more likely to have MODS (39.5% vs. 19.4%,
P¼0.008) and were more likely to start RRT using CRRT rather
than IHD (72.1% vs. 53.1%, P¼0.036), although the RRT
modality was changed during the disease course in several
patients.
Outcomes of patients with anuric AKI
The in-hospital mortality rate was 44.8%, with 18.7% of
discharged patients being dependent on dialysis. Patients with
anuric AKI had a higher rate of in-hospital death (60.5% vs.
Table 3. Clinical characteristics and outcomes of patients with acute kidney injury who required renal replacement therapy
Anuric AKI (n¼43) Oliguric AKI (n¼57) Nonoliguric AKI (n¼103) Pn P1† P2‡
At start of dialysis
Serum Cr (mg/dL) 3.872.2 4.272.8 4.972.9 0.071 0.050 0.091
ICU treatment 81.4 86.0 70.9 0.071 0.030 0.543
Vasoactive drugs 53.5 49.1 42.7 0.453 0.262 0.390
Mechanical ventilator 46.5 50.9 38.9 0.215 0.095 0.492
RRT mode (CRRT) 72.1 64.9 46.6 0.007 0.003 0.036
MODS 39.5 29.8 13.6 0.002 0.001 0.008
Peak serum Cr (mg/dL) 5.372.7 5.072.8 5.472.9 0.701 0.465 0.980
In-hospital deaths 60.5 52.6 34.0 0.005 0.002 0.025
Survivors (n¼112)
RRT dependence for at least 3 mo 41.2 22.2 10.3 0.010 0.012 0.013
n P obtained by one-way ANOVA or χ2 test among three groups.
† P1 obtained by Student t test or Fisher’s exact test between two groups (anuricþoliguric vs. nonoliguric).
‡ P2 between two groups (anuric vs. oliguricþnonoliguric).
Data are presented as mean7SD values or %.
ANOVA, analysis of variance; AKI, acute kidney injury; CRRT, continuous renal replacement therapy; Cr, creatinine; ICU, intensive care unit; MODS,
multiple organ dysfunction syndrome; RRT, renal replacement therapy; SD, standard deviation.
Figure 2. Overall survival curves according to the volume of urine at
the time of initiation of renal replacement therapy.
Table 2. Baseline characteristics of patients with acute kidney injury who required renal replacement therapy
Anuric AKI (n¼43) Oliguric AKI (n¼57) Nonoliguric AKI (n¼103) Pn P1† P2‡
Age (y) 59.4719.9 64.0714.6 66.1714.6 0.072 0.071 0.058
Male sex 62.8 49.1 63.1 0.195 0.256 0.605
Baseline Cr (mg/dL) 1.0170.24 1.0370.34 1.1270.36 0.163 0.057 0.269
Baseline eGFR (mL/min/1.73 m2) 75.1721.0 73.9723.6 70.4724.6 0.514 0.256 0.433
Comorbidities
CKD 26.3 31.4 48.0 0.028 0.011 0.046
CKD(3) 21.1 26.9 42.9 0.024 0.009 0.056
Diabetes 22.0 36.8 42.6 0.069 0.105 0.030
Liver cirrhosis 5.0 17.0 6.0 0.047 0.205 0.532
Malignancy 26.2 21.4 18.8 0.614 0.488 0.396
n P, obtained by one-way ANOVA or χ2 test among three groups.
† P1, obtained by Student t test or Fisher’s exact test between two groups (anuricþoliguric vs. nonoliguric).
‡ P2, between two groups (anuric vs. oliguricþnonoliguric).
Data are presented as mean7SD values or %.
ANOVA, analysis of variance; AKI, acute kidney injury; CKD, chronic kidney disease; Cr, creatinine; eGFR, estimated glomerular ﬁltration rate; RRT,
renal replacement therapy; SD, standard deviation.
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RRT among the survivors (41.2% vs. 13.7%, P¼0.013) than
patients with nonanuric AKI (Table 3).We plotted Kaplan–Meier survival curves stratiﬁed by urine
volumes at the time of initiation of renal replacement therapy.
Fig. 2 shows that a decreased volume of urine was associated with
lower survival (P¼0.0019 by the log-rank test).
Table 4 shows the factors that signiﬁcantly correlated with
survival based on the univariate and multivariate comparisons
in the Cox proportional hazards model. An univariate analysis
demonstrated that septic AKI, HA-AKI, the presence of liver
cirrhosis, the use of vasopressors and mechanical ventilation, a
requirement for CRRT, lower serum Cr at initiation of RRT, and
the presence of anuria were associated with lower survival,
whereas the presence of pre-existing CKD was associated with
greater survival.
After multivariate adjustment, septic AKI, the use of
mechanical ventilation, low serum Cr levels at the initiation
of RRT, and the presence of anuria remained independently
associated with the 90-day mortality in the heterogeneous
population in whom RRT was started for AKI. Patients with
anuric AKI had a 1.86-fold increased risk of death within 90
days compared with the patients with nonanuric AKI.
Stratiﬁed analysis and subgroup analysis
As pre-existing CKD was, unexpectedly, signiﬁcantly more
common in patients with nonanuric AKI and was associated with
lower mortality in the univariate analysis, we stratiﬁed patients
Table 4. Univariate and multivariate analyses for predicting 90-day mortality rates
Univariate analysis Multivariate analysis n
Crude HR (95% CI) P Adjusted HR (95% CI) P
Age (y) 1.00 (0.99–1.02) 0.513
Male sex 1.31 (0.86–2.01) 0.214
Cause of AKI (septic) 2.64 (1.71–4.07) <0.001 1.69 (1.04–2.76) 0.036
Cause of AKI (postoperative) 0.41 (0.16–1.01) 0.052
Hospital-acquired AKI 1.77 (1.17–2.67) 0.007
Baseline Cr (mg/dL) 0.56 (0.27–1.16) 0.119
Baseline eGFR (mL/min/1.73 m2) 1.01 (1.00–1.02) 0.128
Comorbidities
CKD 0.52 (0.28–0.96) 0.048
Diabetes 0.77 (0.49–1.21) 0.263
Liver cirrhosis 1.99 (1.05–3.77) 0.033
Malignancy 1.09 (0.66–1.79) 0.745
At the time of dialysis
Vasoactive drug 4.93 (3.10–7.86) <0.001
Mechanical ventilation 7.36 (4.48–12.08) <0.001 5.15 (2.89–9.18) <0.001
RRT Mode (CRRT) 4.10 (2.46–6.81) <0.001
Serum Cr (mg/dL) 0.67 (0.59–0.77) <0.001 0.77 (0.67–0.90) 0.002
Anuric AKI 1.90 (1.21–3.00) 0.006 1.86 (1.11–3.11) 0.019
n Variables with Po0.05 in the univariate analyses were assessed as independent predictors using the multivariate model by the forward conditional
method.
AKI, acute kidney injury; CI, conﬁdence interval of the estimated HR; CKD, chronic kidney disease; CRRT, continuous renal replacement therapy;
Cr, creatinine; eGFR, estimated glomerular ﬁltration rate; HR, hazard ratio estimated from the Cox proportional hazard model; RRT, renal replacement
therapy.
Table 5. Clinical characteristics according to the presence of chronic kidney disease
Variable Without prior CKD With prior CKD P
Age (y) 61.1717.1 69.7712.1 o0.001
Male sex 64.4 49.3 0.051
Baseline Cr (mg/dL) 0.9070.17 1.4570.34 o0.001
Baseline eGFR (mL/min/1.73 m2) 84.6717.6 47.8714.7 o0.001
At the time of RRT initiation
Vasoactive drugs 51.5 38.0 0.077
Mechanical ventilation 47.7 36.6 0.140
Modality of RRT (CRRT) 64.4 43.7 0.005
MODS 28.8 14.1 0.024
Serum Cr (mg/dL) 5.5773.0 3.1471.57 0.003
Anuric AKI 24.6 13.9 0.056
AnuriaþOliguric AKI 55.3 34.7 0.007
Peak serum Cr (mg/dL) 4.9772.66 5.7472.88 0.070
Outcome
In-hospital mortality 50.8 33.8 0.026
RRT dependence for at least 3 mo 16.9 19.1 0.806
Data are presented as mean7SD values or %.
AKI, acute kidney injury; CKD, chronic kidney disease; Cr, creatinine; CRRT, continuous renal replacement therapy; eGFR, estimated glomerular
ﬁltration rate; MODS, multiple organ dysfunction syndrome; RRT, renal replacement therapy; SD, standard deviation.
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characteristics and outcomes (Table 5). The mean baseline eGFR
was 84.6717.6 mL/min/1.73 m2 and 47.8714.7 mL/min/1.73 m2
in the non-CKD and CKD groups, respectively. Patients without
pre-morbid CKD were younger, predominantly male, and
were associated with a higher acuity of illness, as evidenced by
the need for more frequent CRRT and MODS at the initiation of
dialysis, suggesting that the insult causing AKI may have been
greater.
In addition, we performed a subgroup analysis among
patients who did not have MODS (n¼155). Anuria was not
signiﬁcantly associated with a lower survival in the multi-
variate Cox proportional hazards model. However, the pre-
sence of anuria was the only signiﬁcant predictor of long-term
dependence on RRT among discharged patients in themultivariate Cox regression analysis (hazard ratio 3.124; con-
ﬁdence interval 1.25–7.83; P¼0.015; data not shown).Discussion
We found that anuric AKI was present in a substantial
proportion of patients with AKI who required dialysis. Sepsis
was the most common cause contributing to the development of
AKI in both the anuric and nonanuric AKI groups. Postoperative
AKI and CRS were the other main causes of anuric AKI and 60.5%
of the cases of anuric AKI occurred in hospital. Patients with
anuric AKI were younger, had a lower prevalence of pre-morbid
CKD and diabetes, and were more likely to have MODS than
patients with nonanuric AKI. Patients with anuric AKI had a
Kidney Res Clin Pract 34 (2015) 13–1918higher rate of long-term dependence on RRT and a lower
survival rate. After controlling for potential confounders in the
multivariate Cox analysis, the presence of anuria remained
independently associated with a higher risk of death.
Although this study was conducted at a single center, it has
several important strengths. First, our cohort included patients
who received acute RRT for AKI, by both hemodialysis and
CRRT, in the ICU and on other wards. Although there have been
many advances in the deﬁnitions and epidemiology of AKI
during the past decade, our current understanding is based
almost exclusively on studies of critically ill patients in the ICU.
The incidence of patients receiving their ﬁrst RRT for AKI in the
wards is reported to be up to 40–50% [8]. In this study, 21.2% of
the total cohort received their ﬁrst RRT in the ward; even for
patients with anuric AKI, 18.6% of acute dialysis was performed
in the wards (postoperative, rhabdomyolysis, and acute
tubulo-interstitial nephritis). Notably, 41.8% of the patients
with anuric AKI did not have shock, did not require vasoactive
drugs nor mechanical ventilation, and had no evidence of
MODS. Second, we captured extensive data on comorbidities,
which allowed us to adjust for these factors when considering
the outcomes. In particular, we recorded the baseline serum Cr
level of each patient, whereas many previous studies on CKD
have only determined the presence of CKD, used admission
databases for the baseline Cr, or assigned a GFR of 75 mL/min/
1.73 m2 to patients without a known history of CKD. Third, we
assessed the inﬂuence of the volume of urine in the most
severe form of AKI using the AKIN urine output criteria.
Overall, sepsis was the primary contributing factor in 47.2%
of patients, which is in accordance with the ﬁndings of several
studies, with rates ranging from 32% to 48% in a cohort of ICU
patients [9–11]. Moreover, sepsis was the most common cause
of anuric AKI (41.8%) and was an independent risk factor for
mortality.
The overall in-hospital mortality rate in the cohort was
44.8%, which is similar to the mortality rates in previous
studies: 38–65.9% (in-hospital) and 48.3% (90-day) in patients
with AKI requiring dialysis [8,12,13]. However, the clinical
outcomes were signiﬁcantly worse in patients with anuric and
oliguric AKI, despite all the patients with severe AKI requiring
dialysis and the peak serum Cr concentrations being compar-
able among groups. Patients with anuric AKI had higher in-
hospital mortality rates and were more likely to become
dependent on dialysis than patients with nonanuric AKI.
Severe AKI in which the GFR falls to very low levels is not
necessarily associated with a parallel reduction in the output of
urine, which can vary from oliguria to relatively normal values
[14]. Although oliguric AKI has previously been found to be
associated with a poor prognosis compared with nonoliguric
AKI, the exact mechanisms remain uncertain [14–17]. Pharma-
cological conversion from oliguric to nonoliguric status has not
resulted in improved AKI survival [18]. There are several
possible explanations for the poor prognosis of patients with
anuric AKI in this present. First, the severity of parenchymal
structural change may be greater in patients with anuric AKI
than in patients with nonanuric AKI, despite comparable peak
serum Cr levels. It has been previously shown in animal models
that tubular damage was more pronounced in oliguric kidneys
than in nonoliguric kidneys, although the glomerular injuries
were not signiﬁcantly different [19]. Therefore it is possible that
patients with anuric AKI have more tubular injuries and greater
tubular back-leakage, although the GFR might be comparable
among groups. Second, it is likely that anuria frequently occursin the context of multi-organ failure and the critical illness that
underlies the AKI becomes overwhelming. This explanation is
supported by the results showing that anuric AKI was more
frequently associated with MODS and requirement for CRRT,
despite the comparable hemodynamic instability (e.g., the use
of vasoactive drugs or ICU care). Third, maintaining urine
output may confer direct outcome beneﬁts. It is easier to
control the volume status, hemodynamic stability, and RRT
interval in nonoliguric patients. It has also been reported that
excessive ﬂuid retention per se is an independent risk factor for
mortality, although we did not assess the ﬂuid balance in this
study [20].
An interesting ﬁnding was that pre-existing CKD or dia-
betes were associated with a maintained urine volume rather
than anuria (Table 2). It is well-known that underlying CKD
increases the risk of developing AKI (i.e., it predisposes
patients to AKI) [21] and recent studies have suggested that
AKI accelerates the progression of CKD [22]. However, the
inﬂuence of pre-existing CKD on AKI is unclear.
In terms of the outcome of AKI, previous studies have not
infrequently described that prior CKD is associated with lower
in-hospital mortality rates for critically ill patients with AKI
[8,23,24]. In this study, the presence of CKD was associated
also with better survival in the univariate analysis. One
plausible explanation for this paradoxical association is that
patients with underlying CKD may require a lower burden of
disease to reach the point where dialysis is needed, whereas
those without CKD represent an extremely ill cohort; our
explanation is supported by the results in Table 5, which show
that patients without prior CKD were more frequently asso-
ciated with a requirement for CRRT and MODS. More impor-
tantly, pre-existing CKD was not independently associated
with mortality after adjusting for other covariates in the
multivariate Cox proportional hazards model.
Apart from the relation between the outcome of AKI and
pre-existing CKD, there are limited data about the inﬂuence of
CKD on the clinical features of AKI. In this study, prior CKD was
associated with maintained urine volume rather than oliguria,
which may have potential explanations. First, as mentioned
earlier, CKD patients have a lower burden of disease and start
RRT at an earlier stage. Hence the degree of renal structural
injury might be lower in patients with CKD than in patients
without CKD. Second, patients with CKD may have an altered
susceptibility to the insults that cause AKI by innate mechan-
isms such as “ischemic preconditioning” [25]. Therefore
younger patients and those without prior CKD may fail a
kidney “stress test” more easily after exposure to acute insults
and the clinical features may show as “anuria”, whereas
patients with CKD could maintain their urine output to some
degree by unclear mechanisms. The resulting short-term and
long-term prognoses of AKI between the two groups might be
worthy of further research.
In addition, as only patients in the early stages of CKD were
included in this study, our ﬁndings should be interpreted with
caution; patients with advanced CKD or end-stage renal disease
might show different patterns of disease course. In fact, Oppert
et al [26] have previously reported that the ICU and hospital
mortality rates were markedly higher in patients with pre-
existing dialysis-dependent renal failure than in those with CKD
not dependent on dialysis or those without AKI.
In conclusion, anuric AKI was not rare, with the most common
cause of AKI being sepsis. Anuric AKI was more frequently
observed in younger patients without prior CKD and was
Choi et al / Anuria in acute kidney injury 19associated with higher mortality rates and dependence on RRT.
Whether the renal outcomes of patients with anuric, oliguric, and
nonoliguric AKI will continue to diverge after hospital discharge
remains uncertain, but deserves further investigation.Conﬂict of interest
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